-

Core Team

Executive team

Core Team

...

A Serial Entrepreneur

Andrew Xu PhD
Chairman & CEO
...

Expert in R&D & Ops Management

Emily Li EMBA
COO
...

Bridging between Capital and Industry

Maggie Chen CPA
CFO
...

 

Ann Huang
CHO
Andrew Xu PhD
Chairman & CEO

A Serial Entrepreneur

• 25-year+ industrial experience, with proven expertise in leading business development, organization transforming, global business operations & corporate M&A.

• Served as the President and Vice Chairman of PORTON Pharmaceutical, leading the company through equity reforms and IPO (SZ300363), and overseeing multiple international acquisitions.

Andrew Xu PhD
Chairman & CEO

A Serial Entrepreneur

• 25-year+ industrial experience, with proven expertise in leading business development, organization transforming, global business operations & corporate M&A.

• Served as the President and Vice Chairman of PORTON Pharmaceutical, leading the company through equity reforms and IPO (SZ300363), and overseeing multiple international acquisitions.

Emily Li EMBA
COO

Expert in R&D & Ops Management

• 15+ years’ experience in novel therapeutic development, product registration application & management of operations. Oversaw dozens of innovative drug development projects.

• Served as the Associate GM at Shanghai Tracing Bio-technology Co., Ltd.

Maggie Chen CPA
CFO

Bridging between Capital and Industry

• Over 20 years of experience in the pharmaceutical industry and auditing experience with the Big Four accounting firms, having rich expertise in corporate financing, IPOs, M&As, comprehensive financial management, and capital operations.

• Served as Operating Partner at C-Bridge Capital, Vice President and CFO at Fosun Medical Group, and CFO at PORTON Pharmaceutical.

Ann Huang
CHO

• Ann Huang holds Bachelor of Science in physics from Fudan University and Master of Business Administration from China Europe International Business School.

• Ann Huang joins with over 20 years human resources management experience in start-ups, private owned companies, and public listed companies. She has been through M&As and IPO processes and has intensive experience working in cross cultural environment. 

Back Top